PROMONITOR FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS TREATED WITH ADALIMUMAB IN ENGLAND AND WALES

被引：0
|
作者：
Tikhonova, I. A. [1 ]
Bello, S. [1 ]
Salmon, A. [1 ]
Robinson, S. [1 ]
Hemami, Rezaei M. [1 ]
Haigh, R. C. [2 ]
Jani, M. [3 ]
McDonald, T. J. [1 ]
Hoyle, M. [1 ]
机构：
[1] Univ Exeter, Exeter, Devon, England
[2] Royal Devon & Exeter Hosp, Exeter, Devon, England
[3] Univ Manchester, Manchester, Lancs, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS68
引用
下载
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [11] THERAPEUTIC DRUG MONITORING: STANDARDIZATION OF PROMONITOR QUICK IFX AND PROMONITOR QUICK ADL POINT OF CARE TESTS WITH WHO INTERNATIONAL STANDARDS FOR THE QUANTIFICATION OF INFLIXIMAB AND ADALIMUMAB IN WHOLE BLOOD AND SERUM
    Ametzazurra, A.
    Pascual, J.
    Del Rio, L.
    Urigoitia, A.
    Nagore, D.
    Ruiz-Arguello, M. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1304 - 1305
  • [12] Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab
    Filippucci, E.
    Iagnocco, A.
    Salaffi, F.
    Cerioni, A.
    Valesini, G.
    Grassi, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1433 - 1437
  • [13] SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND ETANERCEPT
    Nguyen, M.
    Velthuis, K.
    Scholl, J.
    Jansen, J.
    Kosse, L.
    Ten Klooster, P.
    Jessurun, N.
    Vonkeman, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1122 - 1122
  • [14] Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
    Ametzazurra, A.
    Pascual, J.
    Del Rio, L.
    Urigoitia, A.
    Nagore, D.
    Ruiz-Arguello, M. B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I353 - I354
  • [15] Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
    Ametzazurra, A.
    Pascual, J.
    Del Rio, L.
    Urigoitia, A.
    Nagore, D.
    Ruiz-Arguello, M. B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I353 - I354
  • [16] Health economic evaluation of patients with rheumatoid arthritis (RA) treated with adalimumab
    Vanoverbeke, N
    Annemans, L
    Cauchie, P
    Hendrickx, E
    VALUE IN HEALTH, 2004, 7 (06) : 663 - 663
  • [17] Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis
    Medina, Frederic
    Plasencia, Chamaida
    Goupille, Philippe
    Ternant, David
    Balsa, Alejandro
    Mulleman, Denis
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 364 - 369
  • [18] Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?
    Bastida, Carla
    Ruiz, Virginia
    Pascal, Mariona
    Yague, Jordi
    Sanmarti, Raimon
    Soy, Dolors
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 962 - 975
  • [19] IS THERE A POTENTIAL FOR THERAPEUTIC DRUG MONITORING OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY PRACTICE?
    Layegh, Z.
    L'Ami, M. J.
    Bastida, C.
    Huitema, A. D.
    Krieckaert, C.
    Nurmohamed, M. T.
    Rispens, T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 966 - 966
  • [20] Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease
    El-Matary, Wael
    CROHNS & COLITIS 360, 2019, 1 (03)
12345